Ameriprise
RDHL

Ameriprise’s Redhill Biopharma RDHL Stock Holding History

Ameriprise’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12
Closed -$63K – 3684
2018
Q1 		$63K Buy
+12
New +$69.1K ﹤0.01% 3581

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Ameriprise's RDHL Position: Q2 2018 in Review

Ameriprise sold out of Redhill Biopharma (RDHL) in Q2 2018, closing a stake of 12 shares — an estimated $63K sold.

Ameriprise first reported a position in RDHL in Q1 2018 and held it in 1 quarter. The position peaked at $63K in Q1 2018. 30 funds tracked by Wall St. Rank hold RDHL as of Q2 2018.

  • Ameriprise reported no remaining Redhill Biopharma position as of Q2 2018 after selling out during the quarter.
  • Ameriprise sold 12 Redhill Biopharma shares in Q2 2018, an estimated $63K.
  • Ameriprise first reported a position in Redhill Biopharma in Q1 2018 and held it in 1 quarter.
  • Ameriprise's Redhill Biopharma position peaked at $63K in Q1 2018.
  • 30 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2018.

Based on Ameriprise's 13F filing for Q2 2018, filed 14 Aug 2018.